Sunita Arun Borade^1*, C N Makhale², Purvez Grant³, Manisha Dhobe⁴

¹Senior CCU Consultant, ²Senior Cardiologist, ³Chief Cardiologist, ⁴HOD CCU, Department of Cardiology, Ruby Hall Clinic, Pune, Maharashtra, INDIA.

Email: sntbrd24@gmail.com

REFERENCES

1. Meenakshisundaram R, Senthilkumaran S, Thirumalai Kolundu Subramanian P, et al.: Status of acute myocardial infarction in Southern India during COVID-19 lockdown: a multicentric study. Mayo Clin Proc Innov Qual Outcomes 2020; 4: 506–10.
2. Ramakrishnan S, Jabir A, Jayagopal PB, Mohanan PP, Nair VK, Das MK, et al., Pattern of acute MI admissions in India during COVID-19 era: A Cardiological Society of India study - Rationale and design. Indian Heart J. 2020 Nov-Dec;72(6):541-546.
3. De Filippo O, D’Ascenzo F, Angelini F, et al.: Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med 2020; 383: 88–9.
4. Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ: Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J 2020; 41: 1852–3.
5. Kapoor A, Yadav R. Will the hidden specter of acute coronary syndrome (ACS) and ST-segment elevation myocardial infarction (STEMI) emerge from the avalanche of COVID-19? Indian Heart J. 2020 May-Jun;72(3):192-193.
6. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A,. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345.
7. Kulkarni P, Mahadevappa, COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions, M. Postgrad Med J 2020;96:436–437.
8. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis 2020:S0033–620.
9. Zachariah G, Ramakrishnan S, Das MK, Jabir A, Jayagopal PB, Venugopal K, Mani K,; CSI-AMI Study group. Changing pattern of admissions for acute myocardial infarction in India during the COVID-19 pandemic. Indian Heart J. 2021 Jul-Aug;73(4):413-423.
10. Baumhardt M, Dreyhaupt J, Winsauer C, Stuhler L, Thiessen K, Stephan T, Markovic S, Rottbauer W, Imhof A, Rattka M: The effect of the lockdown on patients with myocardial infarction during the COVID-19 pandemic—a systematic review and meta-analysis. Dtsch Arztebl Int 2021; 118: 447–53.
11. Fardman A, Zahger D, Orvin K, Oren D, Kofman N, Mohsen J, et al. (2021) Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes—A multicenter registry. PLoS ONE 16(6): e0253524.
12. Foo CY, Bonsu KO, Nallamothu BK, Reid CM, Dhippayom T, Reidpath DD, Chaiyakunapruk N. Coronary intervention door-to balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart. 2018 Aug;104(16):1362-1369.
13. Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, Fleischmann C, et al., Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018 Apr 1;39(13):1065-1074.
14. Zeng J, Huang J, Pan L.How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med. 2020 Jun;46(6):1111-1113.
15. Shekhar AC, Effiong A, Ruskin KJ, et al. COVID-19 and the prehospital incidence of acute cardiovascular events (from the nationwide US EMS). Am J Cardiol. 2020;134:152e153.
16. Mahajan V, Singh T, Azad C. Using Telemedicine During the COVID-19 Pandemic. Indian Pediatr. 2020 Jul 15;57(7):652-657.